LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Inventories
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2024-08-31, per its 10-K filed 2024-11-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2024-11-26
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for the quarter ending 2024-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for the quarter ending 2024-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for the quarter ending 2024-02-29 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for the quarter ending 2023-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for fiscal 2024 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for fiscal 2023 was -$43.07K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for fiscal 2022 was -$1.98K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in inventories for fiscal 2021 was -$95.04K, a 2355.80% decline from fiscal 2020.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | $0.00 derived: sum of 3 quarters · filed 2024-11-26 | $0.00 10-K · filed 2024-11-26 | |||
| 2024-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $0.00 derived: sum of 2 quarters · filed 2024-07-12 | $0.00 10-Q · filed 2024-07-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-26 | |||
| 2024-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $0.00 10-Q · filed 2024-04-09 | $0.00 derived: sum of 3 quarters · filed 2024-11-26 | -$76.78K derived: sum of 4 quarters · filed 2024-11-26 | |||
| 2023-11-30 | $0.00 10-Q · filed 2024-01-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | -$76.78K derived: sum of 3 quarters · filed 2024-11-26 | -$12.28K derived: sum of 4 quarters · filed 2024-11-26 | |||
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$76.78K derived: sum of 2 quarters · filed 2024-11-26 | -$12.28K derived: sum of 3 quarters · filed 2024-11-26 | -$43.07K 10-K · filed 2024-11-26 | $43.07K 10-K · filed 2023-11-20 | ||
| 2023-05-31 | -$76.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | -$12.28K derived: sum of 2 quarters · filed 2024-07-12 | -$43.07K 10-Q · filed 2024-07-12 | $43.07K 10-Q · filed 2023-07-14 | -$35.85K derived: sum of 4 quarters · filed 2024-07-12 | ||
| 2023-02-28 | $64.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $33.71K 10-Q · filed 2024-04-09 | -$33.71K 10-Q · filed 2023-04-14 | $40.93K derived: sum of 3 quarters · filed 2024-04-09 | $30.57K derived: sum of 4 quarters · filed 2024-04-09 | ||
| 2022-11-30 | -$30.79K 10-Q · filed 2024-01-12 | -$23.57K derived: sum of 2 quarters · filed 2024-01-12 | -$33.93K derived: sum of 3 quarters · filed 2024-01-12 | -$29.86K derived: sum of 4 quarters · filed 2024-01-12 | |||
| 2022-08-31 | $7.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | -$3.14K derived: sum of 2 quarters · filed 2023-11-20 | $935.00 derived: sum of 3 quarters · filed 2023-11-20 | -$1.98K 10-K · filed 2023-11-20 | $1.98K 10-K · filed 2022-11-28 | ||
| 2022-05-31 | -$10.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | -$6.28K derived: sum of 2 quarters · filed 2023-07-14 | -$9.20K 10-Q · filed 2023-07-14 | $9.20K 10-Q · filed 2022-07-14 | -$32.26K derived: sum of 4 quarters · filed 2023-07-14 | ||
| 2022-02-28 | $4.08K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | $1.16K 10-Q · filed 2023-04-14 | -$21.90K derived: sum of 3 quarters · filed 2023-04-14 | -$110.76K derived: sum of 4 quarters · filed 2023-04-14 | |||
| 2021-11-30 | -$2.91K 10-Q/A · filed 2023-01-18 | -$25.98K derived: sum of 2 quarters · filed 2023-01-18 | -$114.83K derived: sum of 3 quarters · filed 2023-01-18 | -$104.02K derived: sum of 4 quarters · filed 2023-01-18 | |||
| 2021-08-31 | -$23.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$111.92K derived: sum of 2 quarters · filed 2022-11-28 | -$101.10K derived: sum of 3 quarters · filed 2022-11-28 | -$95.04K 10-K · filed 2022-11-28 | $95.04K 10-K · filed 2021-11-29 | ||
| 2021-05-31 | -$88.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | -$78.04K derived: sum of 2 quarters · filed 2022-07-14 | -$71.98K 10-Q · filed 2022-07-14 | $71.98K 10-Q · filed 2021-07-15 | -$54.37K derived: sum of 4 quarters · filed 2022-07-14 | ||
| 2021-02-28 | $10.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $16.88K 10-Q · filed 2022-04-11 | $34.49K derived: sum of 3 quarters · filed 2022-04-11 | $24.20K derived: sum of 4 quarters · filed 2022-04-11 | |||
| 2020-11-30 | $6.07K 10-Q · filed 2021-01-14 | $23.68K derived: sum of 2 quarters · filed 2021-11-29 | $13.39K derived: sum of 3 quarters · filed 2021-11-29 | $4.12K derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2020-08-31 | $17.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $7.32K derived: sum of 2 quarters · filed 2021-11-29 | -$1.95K derived: sum of 3 quarters · filed 2021-11-29 | $4.21K 10-K · filed 2021-11-29 | -$4.21K 10-K · filed 2020-10-15 | ||
| 2020-05-31 | -$10.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | -$19.56K derived: sum of 2 quarters · filed 2021-07-15 | -$13.40K 10-Q · filed 2021-07-15 | $13.40K 10-Q · filed 2020-06-29 | -$67.09K derived: sum of 4 quarters · filed 2021-07-15 | ||
| 2020-02-29 | -$9.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | -$3.11K 10-Q · filed 2021-04-14 | -$56.80K derived: sum of 3 quarters · filed 2021-04-14 | $23.45K derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | $6.16K 10-Q · filed 2021-01-14 | -$47.54K derived: sum of 2 quarters · filed 2021-01-14 | $32.72K derived: sum of 3 quarters · filed 2021-01-14 | $24.07K derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$53.70K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $26.56K derived: sum of 2 quarters · filed 2020-10-15 | $17.91K derived: sum of 3 quarters · filed 2020-10-15 | $47.34K 10-K · filed 2020-10-15 | |||
| 2019-05-31 | $80.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | $71.61K derived: sum of 2 quarters · filed 2020-06-29 | $101.04K 10-Q · filed 2020-06-29 | $112.16K derived: sum of 4 quarters · filed 2020-06-29 | |||
| 2019-02-28 | -$8.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $20.79K 10-Q · filed 2020-04-03 | $31.90K derived: sum of 3 quarters · filed 2020-04-03 | $49.47K derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2018-11-30 | $29.43K 10-Q · filed 2020-01-09 | $40.55K derived: sum of 2 quarters · filed 2020-01-09 | $58.12K derived: sum of 3 quarters · filed 2020-01-09 | $48.65K derived: sum of 4 quarters · filed 2020-01-09 | |||
| 2018-08-31 | $11.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $28.69K derived: sum of 2 quarters · filed 2019-11-14 | $19.22K derived: sum of 3 quarters · filed 2019-11-14 | $33.02K 10-K · filed 2019-11-14 | |||
| 2018-05-31 | $17.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $8.10K derived: sum of 2 quarters · filed 2019-07-08 | $21.91K 10-Q · filed 2019-07-08 | $24.66K derived: sum of 4 quarters · filed 2019-07-08 | |||
| 2018-02-28 | -$9.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $4.34K 10-Q · filed 2019-04-15 | $7.09K derived: sum of 3 quarters · filed 2019-04-15 | -$7.17K derived: sum of 4 quarters · filed 2019-04-15 | |||
| 2017-11-30 | $13.81K 10-Q · filed 2019-01-11 | $16.56K derived: sum of 2 quarters · filed 2019-01-11 | $2.30K derived: sum of 3 quarters · filed 2019-01-11 | -$4.19K derived: sum of 4 quarters · filed 2019-01-11 | |||
| 2017-08-31 | $2.75K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$11.51K derived: sum of 2 quarters · filed 2018-11-14 | -$18.00K derived: sum of 3 quarters · filed 2018-11-14 | $1.06K 10-K · filed 2018-11-14 | |||
| 2017-05-31 | -$14.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | -$20.75K derived: sum of 2 quarters · filed 2018-07-13 | -$1.69K 10-Q · filed 2018-07-13 | $9.80K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-02-28 | -$6.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $12.57K 10-Q · filed 2018-04-12 | $24.06K derived: sum of 3 quarters · filed 2018-11-14 | ||||
| 2016-11-30 | $19.06K 10-Q · filed 2018-01-12 | $30.55K derived: sum of 2 quarters · filed 2018-11-14 | |||||
| 2016-08-31 | $11.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $10.78K 10-K · filed 2018-11-14 | |||||
| 2016-05-31 | -$714.00 10-Q · filed 2017-07-14 | ||||||
| 2016-02-29 | -$26.55K 10-Q · filed 2017-04-14 | ||||||
| 2015-11-30 | $31.31K 10-Q · filed 2017-01-13 | $119.95K derived: sum of 2 quarters · filed 2017-01-13 | |||||
| 2015-08-31 | $88.64K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $167.99K 10-K · filed 2016-11-29 | |||||
| 2015-05-31 | $79.34K 10-Q · filed 2016-07-13 | ||||||
| 2015-02-28 | $77.59K 10-Q · filed 2016-04-13 | ||||||
| 2014-11-30 | $18.80K 10-Q · filed 2016-01-08 | $18.80K derived: sum of 2 quarters · filed 2016-01-08 | |||||
| 2014-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $0.00 10-K · filed 2015-11-27 | |||||
| 2014-05-31 | $0.00 10-Q · filed 2015-07-14 | ||||||
| 2014-02-28 | $0.00 10-Q · filed 2015-04-14 | ||||||
| 2013-11-30 | $0.00 10-Q · filed 2015-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |